Guyana vs Uruguay: Tuberculosis patients living with HIV receiving antiretroviral therapy
Guyana
53 patients
in 2021
Uruguay
52 patients
in 2021
Guyana rank
87th
Uruguay rank
88th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Guyana
- Uruguay
How they compare
Guyana currently reports 53 patients against 52 patients in Uruguay, a difference of 1 patients.
The two have swapped places 2 times across 16 shared years of data; in 2006 it was Guyana ahead.
Guyana ranks 87th and Uruguay ranks 88th of 183 countries.
Across the 3 decades both report, Guyana averaged higher in 2 and Uruguay in 1.
Head to head by decade
| Decade | Guyana | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.25 patients | 20.5 patients | 48.75 patients | Guyana |
| 2010s | 111.2 patients | 67 patients | 44.2 patients | Guyana |
| 2020s | 43.5 patients | 54 patients | 10.5 patients | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Guyana or Uruguay?
- Guyana, at 53 patients against 52 patients in Uruguay as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Guyana and Uruguay?
- 1 patients, with Guyana ahead.
- How many years of comparable data are there for Guyana and Uruguay?
- 16 years are reported by both, from 2006 to 2021.
- How do Guyana and Uruguay rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Guyana ranks 87th and Uruguay ranks 88th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.